Pesquisa | Biblioteca Virtual em Saúde

1.

Updated overall survival and final progression-free survival data for patients with treatment-naive advanced ALK-positive non-small-cell lung cancer in the ALEX study.

Mok, T; Camidge, D R; Gadgeel, S M; Rosell, R; Dziadziuszko, R; Kim, D-W; Pérol, M; Ou, S-H I; Ahn, J S; Shaw, A T; Bordogna, W; Smoljanovic, V; Hilton, M; Ruf, T; Noé, J; Peters, S.

Ann Oncol ; 31(8): 1056-1064, 2020 08.

Artigo em Inglês | MEDLINE | ID: mdl-32418886

2.

Mechanisms of resistance to selective RET tyrosine kinase inhibitors in RET fusion-positive non-small-cell lung cancer.

Lin, J J; Liu, S V; McCoach, C E; Zhu, V W; Tan, A C; Yoda, S; Peterson, J; Do, A; Prutisto-Chang, K; Dagogo-Jack, I; Sequist, L V; Wirth, L J; Lennerz, J K; Hata, A N; Mino-Kenudson, M; Nardi, V; Ou, S-H I; Tan, D S-W; Gainor, J F.

Ann Oncol ; 31(12): 1725-1733, 2020 12.

Artigo em Inglês | MEDLINE | ID: mdl-33007380

3.

Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.

Shaw, A T; Riely, G J; Bang, Y-J; Kim, D-W; Camidge, D R; Solomon, B J; Varella-Garcia, M; Iafrate, A J; Shapiro, G I; Usari, T; Wang, S C; Wilner, K D; Clark, J W; Ou, S-H I.

Ann Oncol ; 30(7): 1121-1126, 2019 07 01.

Artigo em Inglês | MEDLINE | ID: mdl-30980071

4.

What hides behind the MASC: clinical response and acquired resistance to entrectinib after ETV6-NTRK3 identification in a mammary analogue secretory carcinoma (MASC).

Drilon, A; Li, G; Dogan, S; Gounder, M; Shen, R; Arcila, M; Wang, L; Hyman, D M; Hechtman, J; Wei, G; Cam, N R; Christiansen, J; Luo, D; Maneval, E C; Bauer, T; Patel, M; Liu, S V; Ou, S H I; Farago, A; Shaw, A; Shoemaker, R F; Lim, J; Hornby, Z; Multani, P; Ladanyi, M; Berger, M; Katabi, N; Ghossein, R; Ho, A L.

Ann Oncol ; 27(5): 920-6, 2016 05.

Artigo em Inglês | MEDLINE | ID: mdl-26884591

5.

Clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC.

Ou, S-H I; Jänne, P A; Bartlett, C H; Tang, Y; Kim, D-W; Otterson, G A; Crinò, L; Selaru, P; Cohen, D P; Clark, J W; Riely, G J.

Ann Oncol ; 25(2): 415-22, 2014 Feb.

Artigo em Inglês | MEDLINE | ID: mdl-24478318

6.

Innovative personalized medicine in gastric cancer: time to move forward.

Lee, J; Kim, K-M; Kang, W K; Ou, S-H I.

Clin Genet ; 86(1): 37-43, 2014 Jul.

Artigo em Inglês | MEDLINE | ID: mdl-24749947

7.

The allure of 'ALUR'.

Nagasaka, M; Zhu, V W; Ou, S-H I.

Ann Oncol ; 29(6): 1344-1346, 2018 06 01.

Artigo em Inglês | MEDLINE | ID: mdl-29688274

8.

The frequency and impact of ROS1 rearrangement on clinical outcomes in never smokers with lung adenocarcinoma.

Kim, H R; Lim, S M; Kim, H J; Hwang, S K; Park, J K; Shin, E; Bae, M K; Ou, S-H I; Wang, J; Jewell, S S; Kang, D R; Soo, R A; Haack, H; Kim, J H; Shim, H S; Cho, B C.

Ann Oncol ; 24(9): 2364-70, 2013 Sep.

Artigo em Inglês | MEDLINE | ID: mdl-23788756

9.

Reply to the letter to the editor 'clinical benefit of continuing ALK inhibition with crizotinib beyond initial disease progression in patients with advanced ALK-positive NSCLC' by Ou et al.

Ou, S-H I; Pasi, J.

Ann Oncol ; 25(10): 2093, 2014 Oct.

Artigo em Inglês | MEDLINE | ID: mdl-25035278

10.

Emergence of EGFR G724S mutation in EGFR-mutant lung adenocarcinoma post progression on osimertinib.

Oztan, A; Fischer, S; Schrock, A B; Erlich, R L; Lovly, C M; Stephens, P J; Ross, J S; Miller, V; Ali, S M; Ou, S-H I; Raez, L E.

Lung Cancer ; 111: 84-87, 2017 09.

Artigo em Inglês | MEDLINE | ID: mdl-28838405

11.

Epidemiology of nasopharyngeal carcinoma in the United States: improved survival of Chinese patients within the keratinizing squamous cell carcinoma histology.

Ou, S-H I; Zell, J A; Ziogas, A; Anton-Culver, H.

Ann Oncol ; 18(1): 29-35, 2007 Jan.

Artigo em Inglês | MEDLINE | ID: mdl-17060483

12.

Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis.

Zell, J A; Ou, S-H I; Ziogas, A; Anton-Culver, H.

Ann Oncol ; 17(8): 1255-62, 2006 Aug.

Artigo em Inglês | MEDLINE | ID: mdl-16766595

Biblioteca Virtual em Saúde

Saúde Pública Brasil

Sua seleção (0)

Formato de exportação:

Exportar: